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Abstract
Background: Hyponatraemia (serum sodium < 135 mmol/L) has long been recognized as a complication of malaria. 
However, few studies have been done in non-immune adult populations. It has not been investigated previously how 
hyponatraemia is distributed among the various Plasmodium species, and its association with malaria severity is 
unknown.
The aim of this retrospective cohort study was to determine the prevalence of hyponatraemia and its association with
malaria severity in a large cohort of patients with imported malaria caused by various Plasmodium species.
Methods: All patients that were diagnosed with malaria in the Harbour Hospital and Institute for Tropical Diseases in 
Rotterdam in the period 1999-2009 and who had available serum sodium on admission were included. Severe malaria 
was defined according to the modified WHO criteria. Prevalence of hyponatraemia and its association with malaria 
severity were investigated by univariate comparison, ROC analysis and multivariate logistic regression analysis.
Results: A total of 446 patients with malaria (severe falciparum malaria n = 35, non-severe falciparum malaria n = 280, 
non-falciparum malaria n = 131) was included. Hyponatraemia was present in 207 patients (46%). Prevalence and 
severity of hyponatraemia were greatest in severe falciparum malaria (77%, median serum sodium 129 mmol/L), 
followed by non-severe falciparum malaria (48%, median serum sodium 131 mmol/L), and non-falciparum malaria 
(34%, median serum sodium 132 mmol/L). Admission serum sodium < 133 mmol/L had a sensitivity of 0.69 and a 
specificity of 0.76 for predicting severe malaria. Multivariate logistic regression showed that serum sodium < 131 
mmol/L was independently associated with severe falciparum malaria (odds ratio 10.4, 95% confidence interval 3.1-
34.9). In patients with hyponatraemia, hypovolaemia did not appear to play a significant role in the development of 
hyponatraemia when prerenal azotaemia and haematocrit were considered as surrogate markers for hypovolaemia.
Conclusions: Hyponatraemia is common in imported malaria and is associated with severe falciparum malaria. From a 
clinical point of view, the predictive power of hyponatraemia for severe malaria is limited. The precise 
pathophysiological mechanisms of hyponatraemia in malaria require further study.
Background
Hyponatraemia has long been recognized as a complica-
tion of malaria [1]. The incidence of hyponatraemia in
malaria has mostly been studied in endemic areas focus-
i n g  o n  c h i l d r e n  w i t h  s e v e r e  Plasmodium falciparum
malaria and was approximately 55% [1-3]. Two studies in
adults in Bangladesh and Thailand found incidences of
57% and 37%, respectively [4,5]. However, few studies
have been performed in non-immune populations or in
patients infected with other Plasmodium species.
The pathophysiology of hyponatraemia in malaria
remains unclear but several studies have suggested that
increased secretion of vasopressin, either appropriately
or inappropriately, plays an important role [4,6-10].
Although a recent study suggested that the outcome of
patients with malaria and hyponatraemia is good [4],
cerebral oedema may still occur in rare cases [11].
The aim of this retrospective cohort study was to inves-
tigate the prevalence and severity of hyponatraemia in a
large cohort of predominantly adult non-immune travel-
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lers with imported malaria caused by various Plasmo-
dium species and its relationship with malaria severity.
Methods
Patients
The Harbour Hospital is a 161-bed general hospital
located in Rotterdam, The Netherlands. It also harbours
the Institute of Tropical Diseases, which serves as a
national referral centre. All patients diagnosed with
malaria in our hospital in the 10-year-period between
January 1st  1999 and January 1st  2009 were included.
Patients were identified by screening the malaria data-
base of the Department of Parasitology. Of all patients
thus identified, demographic, clinical and laboratory data
were collected using a standardized form, and subse-
quently stored in an electronic database.
Laboratory investigations
Available laboratory examinations included red and white
blood cells, haematocrit, platelets, serum electrolytes, C-
reactive protein (CRP), total bilirubin, serum creatinine
and urea, liver enzymes, lactate dehydrogenase (LDH),
blood glucose and plasma lactate. Serum sodium concen-
tration was measured using indirect potentiometry
(Beckman Synchron UniCel DxC 600 analyser). Blood
smears (thin and thick films) were obtained from finger
pricks and stained with Giemsa for parasite counts.
Malaria was diagnosed by Quantitative Buffy Coat analy-
sis,  P. falciparum Histidine-Rich-Protein 2 screening
(now ICT Malaria, Binax) and conventional microscopy
with subsequent specification of the Plasmodium species.
Multiple malaria episodes in a single patient were only
regarded as separate cases if caused by true re-infection;
recrudescent infections of P. falciparum and Plasmodium
malariae and relapses of Plasmodium vivax and Plasmo-
dium. ovale were excluded. Patients with a mixed infec-
tion of P. falciparum with another Plasmodium species
were considered as having P. falciparum malaria.
Definitions
Severe malaria: Patients were considered as having
severe P. falciparum malaria if they met predefined modi-
fied World Health Organization (WHO) criteria for
severe malaria on admission or during hospitalization
[12] ("severity criteria"):
• A Glasgow Coma Scale (GCS) score < 11 (indicating
cerebral malaria) or
• Anaemia (haematocrit < 0.20 L/L with parasite
count > 100.000/μL) or
• Jaundice (serum bilirubin > 50 μmol/L with parasite
count > 100.000/μL) or
• Renal impairment (urine output < 400 mL/24 h and
serum creatinine > 250 μmol/L) or
• Hypoglycaemia (blood glucose < 2.2 mmol/L) or
• Hyperparasitaemia (> 10% parasitaemia) or
• Shock (systolic blood pressure < 80 mm Hg with
cold extremities)
Hyponatraemia:  Hyponatraemia was defined as a
serum sodium concentration of less than 135 mmol/L.
Statistical analysis
All data were not Normally distributed (Kolmogorov-
Smirnov test) and are, therefore, presented as medians
and range. Univariate comparisons were performed using
the Kruskall-Wallis test (three groups) with Dunn's post-
hoc tests, or the Mann-Whitney test (two groups). Corre-
lations were analysed using Spearman rho (rs) and Wil-
coxon signed rank test. The prognostic value of serum
sodium for malaria severity was determined by a receiver
operating characteristic (ROC) analysis. To analyse if
hyponatraemia was also independently associated with
malaria severity, a logistic regression analysis was per-
formed using a backward stepwise conditional approach.
In the latter analysis only patients with falciparum
malaria were included (because only the falciparum spe-
cies can cause severe malaria) and the presence of severe
malaria was defined as the outcome.
Results
Patient characteristics
Serum sodium concentration on admission was available
for 446 of the 477 malaria cases (93.5%), and they com-
prised the study population. Infection was most com-
monly acquired in Africa (75%) and Asia (14%).
Infections with P. falciparum accounted for the majority
of cases (n = 315, 70.6%). P. falciparum infection was clas-
sified as severe (n = 35) or non-severe (n = 280). One
hundred and thirty-one patients had non-falciparum
malaria, which consisted of P. vivax (n = 92, 70%,), P.
ovale (n = 33, 25%) and P. malariae (n = 6, 5%). True re-
infection occurred in 13 patients, and four patients had a
mixed infection of P. falciparum and another Plasmo-
dium species. Table 1 shows the comparison of the demo-
graphic characteristics, vital signs, and laboratory data on
admission in the groups with severe and non-severe falci-
parum malaria, and non-falciparum malaria.
Characteristics of patients with severe malaria
Thirty-two patients fulfilled one or more of the severity
criteria at initial presentation (GCS < 11 n = 3; anaemia
with a parasite count exceeding 100,000 trophozoites per
μL n = 3; icterus with a parasite count exceeding 100,000
trophozoites per μL n = 17; acute oliguric renal insuffi-
ciency n = 4; hypoglycaemia n = 0; hyperparasitaemia n =
12 and shock n = 2, respectively). Three patients did not
fulfil the criteria for severe disease on admission but their
clinical course deteriorated shortly hereafter. Admission
plasma lactate levels were significantly increased invan Wolfswinkel et al. Malaria Journal 2010, 9:140
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patients with severe malaria as compared with patients
with uncomplicated falciparum malaria and patients with
non-falciparum malaria (table 1). Eventually, at admission
to the intensive care unit (ICU), all 35 patients fulfilled
one or more of the severity criteria (cerebral malaria or
impaired conscious level n = 9; anaemia with a parasite
count exceeding 100,000 trophozoites per μL n = 3; ict-
erus with a parasite count exceeding 100,000 trophozo-
ites per μL n = 19; acute oliguric renal insufficiency n = 5;
shock n = 2, respectively). The first arterial blood gas
analysis on ICU showed a median bicarbonate level of 21
mmol/L (range 17 to 26 mmol/L) and a median base defi-
cit of 2 (range -3 to 9). Two patients needed mechanical
ventilation, whereas three patients needed haemodialysis.
Twenty-four patients received exchange transfusion.
Details of this standardized adjunct treatment have been
published elsewhere [13]. One patient with severe falci-
parum malaria died of cerebral malaria.
Hyponatraemia in imported malaria
Hyponatraemia was present in 207 patients (46%). The
distribution of serum sodium in the whole population
seemed to be shifted to lower values (Figure 1). Figure 2
shows the distribution of serum sodium in patients with
severe P. falciparum, non-severe P. falciparum, and non-
falciparum malaria. Only two patients (0.4%) had a serum
sodium concentration exceeding 145 mmol/L. When
only patients with hyponatraemia were considered,
hyponatraemia was more severe in severe falciparum
malaria (median serum sodium 129 mmol/L) compared
with both non-severe falciparum and non-falciparum
malaria (median serum sodium 131 and 132 mmol/L,
respectively, p < 0.05). In the whole population, prerenal
azotaemia (defined as a serum urea: creatinine ratio > 1:
10) was not more common (11/207 or 5.3% vs. 7/239 or
2.9%, p = 0.2) and haematocrit values (median 0.39 vs.
0.39, p = 0.6) were not higher in patients with hyponatra-
Table 1: Patient characteristics at initial presentation
Severe P. falciparum
(n = 35)
Non-severe 
P. falciparum
(n = 280)
Non-falciparum
(n = 131)
P-value*
Demographics
Age, years 44 (4 - 70) 39 (4 - 78) 35.5 (8 - 77) 0.007B
Male, female, n (%) 21 (58), 14 (42) 202 (72), 78 (28) 87 (66), 44 (34) N.S.
Vital signs on admisson
Body temperature, °C 38.2 (36.2 - 41.2) 38.6 (35.7 - 41.0) 38.6 (35.0 - 41.5) N.S.
Pulse rate, beats per minute 101 (50 - 150) 92 (45 - 150) 89 (58 - 138) 0.02A
Systolic blood pressure, mm Hg† 115 (80 - 160) 120 (80 - 90) 120 (70 - 196) N.T.
GCS < 11, n (%)† 3 (9) 0 (0) 0 (0) N.T.
Laboratory data on admission
C-reactive protein, mg/L 184 (91 - 265) 77 (5 - 320) 71 (8 - 213) < 0.0001A
Haematocrit, L/L† 0.35 (0.17 - 0.51) 0.40 (0.19 - 0.54) 0.38 (0.22 - 0.53) N.T.
Leucocyte count, × 109/L 7.1 (3.2 - 18.5) 4.9 (1.3 - 13.2) 5.3 (1.9 - 15.3) < 0.0001A
Thrombocytes, × 109/L 36 (3 - 188) 98 (11 - 433) 94 (10 - 292) < 0.0001A
Serum sodium, mmol/L 130 (115 - 146) 135 (119 - 145) 136 (124 - 148) < 0.0001A
Serum potassium, mmol/L 3.7 (2.7 - 4.7) 3.8 (2.5 - 5.1) 3.8 (2.7 - 5.4) N.S.
Serum creatinine, μmol/L† 114 (48 - 871) 94 (41 - 228) 87 (46 - 477) N.T.
Serum glucose, mmol/L 6.3 (4.1 - 12.5) 6.6 (4.4 - 33.8) 6.4 (4.7 - 22.1) N.S.
Total bilirubin, μmol/L† 53 (15 - 416) 21 (4 - 262) 21.5 (3 - 91) N.T.
Alanine-aminotransferase, U/L 58 (11 - 655) 35 (3 - 265) 31 (6 - 198) 0.001A
Lactate dehydrogenase, U/L 890 (308 - 4113) 455 (224 - 2724) 428 (185 - 1395) < 0.0001A
Plasma lactate (mmol/L) 2,3 (1,2 - 5,8) 1,4 (0,5 - 4,4) 1,3 (0,7 - 3,0) < 0.001B
Parasite load (trophozoites/μL)† 239,200 (520 - 1,110000) 5300 (2 - 385,000) N/A N.T.
Duration hospitalisation, days 8 (3 - 19) 5 (1 - 16) 2 (1 - 11) < 0.0001A+C
* Using Kruskall-Wallis and Dunn's post-hoc tests. Parameters that are included in the modified WHO severity criteria for severe falciparum 
malaria (indicated by † [12]) were not tested (N.T.). N.S. denotes 'not significant'.
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e m i a  a n d  m a l a r i a .  O t h e r  c a u s e s  o f  h y p o n a t r a e m i a
appeared rare. Only three patients with malaria and
hyponatraemia also used drugs associated with hypona-
traemia (1 thiazide diuretic, 1 several diuretics, 1 risperi-
done) [14]. None of the patients had severe heart or liver
failure, and none of the patients had known pre-existing
hyponatraemia. A significant correlation was demon-
strated between sodium levels and CRP levels on admis-
sion for all patients with imported malaria (n = 428; rs = -
0.36; p < 0.0001) but also for patients with infections
solely caused by Plasmodium falciparum (n = 298; rs = -
0.41; p < 0.0001).
Hyponatraemia and malaria severity
The area-under the ROC-curve for the predictive value of
serum sodium concentration for malaria severity was
0.72 for P. falciparum infections and 0.74 for all patients
with malaria (Figure 3). A cut-off of 133 mmol/L was
identified as having the best discriminatory performance
(sensitivity 0.69, specificity 0.76, positive predictive value
0.20, negative predictive value 0.97). Variables significant
on univariate analysis that were not severity criteria
(Table 1) were entered as dichotomous variables in the
multivariate model using different cut-off points. The fol-
lowing parameters were independently associated with
severe falciparum malaria: serum sodium < 131 mmol/L,
CRP > 175 mg/L, LDH > 750 U/L, thrombocytes < 20 ×
109/L and leukocytes > 6.5 × 109/L (Table 2). When the
s e v e r i t y  c r i t e r i a  w e r e  a l s o  e n t e r e d  i n  t h e  m o d e l ,  o n l y
serum sodium < 131 mmol/L and CRP > 175 mg/L
remained independent predictors of severe falciparum
malaria (both p < 0.05).
Clinical course and outcome
The median duration of hospital stay is shown in Table 1.
Three of the 35 patients with severe falciparum malaria
met the criteria for severe malaria only hours after admis-
sion when their parasite counts increased to above cut-off
levels or their clinical course deteriorated. Interestingly,
two of them were hyponatraemic on admission (serum
sodium 130 and 132 mmol/L). Follow-up serum sodium
concentrations were available for 24 of 27 patients with
severe falciparum infection and hyponatraemia. Serum
sodium normalized within 24 hours in seven patients. It
took between 24 and 96 hours in seven patients, and
more than 96 hours in eight patients. In three patients the
time in which serum sodium normalized was unknown.
Patients with more severe hyponatraemia on admission
remained hyponatraemic for a longer period of time (p <
0.01). There was no significant correlation between
sodium levels and GCS in patients with severe malaria (n
= 35; rs = -0.036; p = 0.84).
Discussion
The present study shows that hyponatraemia is common
in patients with imported malaria, and is associated with
severe disease in P. falciparum malaria. The incidence of
hyponatraemia in this study (77% severe P. falciparum,
48% non-severe P. falciparum, and 34% non-falciparum)
is comparable to that found in other studies. Holst et al
[7] found hyponatraemia in 13 of 17 (76%) non-immune
travellers with severe P. falciparum infection, whereas
Kockaerts et al [15] reported an incidence of 53% in a
cohort of 101 patients with imported malaria, although
no differentiation according to Plasmodium species or
severity of malaria was made. In children with imported
malaria, lower incidences were found (5/20 or 25% by
Viani et al [16], 16/192 or 8% by Ladhani et al [2]).
Interestingly, in the present study, a serum sodium <
131 mmol/L, CRP > 175 mg/L, LDH > 750 IU/L, throm-
bocyte count < 20 × 109/L, and leukocyte count > 6.5 ×
109/L were all independently associated with severe falci-
parum malaria (as defined by the modified WHO severity
criteria [12]). Some of these parameters like thrombocy-
topaenia [17] and leukocytosis [18] have been reported as
risk factors for severe malaria or a fatal outcome but this
has not been a universal finding [19]. When the severity
criteria were also entered in the regression model, serum
sodium < 131 mmol/L and CRP > 175 mg/L were the only
remaining independent variables with Odds ratio's of 10.4
(95% Confidence Interval 3.1 - 34.9) and 4.8 (95% CI 1.6 -
15.0) for severe malaria, respectively, suggesting that
determination of these parameters might contribute to an
early recognition of patients with severe malaria on
admission. However, there are some important draw-
backs, which may limit its usefulness in clinical practice.
First, sodium had a poor positive predictive value (0.20)
for severe malaria. The observations that hyponatraemia
may be seen in imported malaria caused by any Plasmo-
dium species as well as in other infectious diseases sug-
Figure 1 Distribution of serum sodium in patients with imported 
malaria.van Wolfswinkel et al. Malaria Journal 2010, 9:140
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gest that hyponatraemia per se is unlikely to represent an
exclusive feature of falciparum malaria but merely
reflects the effects of severity of any disease rather than
malaria itself. Second, hyponatraemia is a well recognized
indicator of disease severity and predictor of mortality
regardless of its cause, as has been observed in several
studies with hospitalized adult patients [20,21]. As such,
the recognition that lower sodium occurs more fre-
quently in severe malaria will probably not significantly
change the monitoring and management of the patient
since most physicians would already have a higher index
of suspicion for a complicated course. Third, the finding
t h a t  s o d i u m  i s  a n  i n d e p e n d e n t  r i s k  f a c t o r  f o r  s e v e r e
malaria contrasts with the findings of two recent studies.
In the first study [22], performed in several malaria-
endemic countries, involving more than 1000 adults indi-
viduals with severe malaria (defined by the same modi-
fied WHO criteria) only base deficit and cerebral malaria
(measured with GCS) but not sodium were found to be
main independent predictors of outcome. Moreover, in
the other study [23] involving 482 individuals with
imported falciparum malaria, sodium was not identified
as an independent risk factor for severe falciparum
malaria. The reason for this discrepancy with the present
Figure 2 Distribution of serum sodium in malaria patients grouped by causative Plasmodium species. Hyponatraemia was present in 27/35 
(77%) of patients with severe P. falciparum infection, in 135/280 (48%) of patients with non-severe P. falciparum infection, and in 45/131 (34%) of pa-
tients with non-falciparum infection. Dashed lines indicate normal reference range. Bars indicate the median.van Wolfswinkel et al. Malaria Journal 2010, 9:140
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findings is not immediately apparent but might relate to
differences in the number of elderly patients [24] and dif-
ferences in ethnicity [23]. For example, of the 482 individ-
uals with imported malaria [23], 68% of the patients were
of black ethnicity, which was associated with a reduced
risk of developing WHO-defined severe falciparum
malaria, whereas white patients had odds that were 8-fold
higher. In the present study patients of black ethnicity
constituted only a minority of the patients. Fourth and
probably most important from a clinical point of view,
other parameters like coma and parameters of impaired
tissue perfusion (such as acidosis [25], elevated lactate
level [25,26] or base deficit [22]) have been reported as
more powerful risk factors for severe malaria or a fatal
outcome than sodium.
Even though the predictive power of hyponatraemia for
severe malaria may be limited in clinical practice, its
pathophysiology is certainly puzzling. Suggested mecha-
nisms are absolute sodium deficit due to cerebral salt
wasting, excessive sweating or loss in the gastrointestinal
or urinary tract [3], and the secretion of vasopressin
which can be either appropriate, in case of volume deple-
tion [4], or inappropriate as in the syndrome of inappro-
priate antidiuretic hormone secretion [10] or reset
osmostat [8]. There is, however, no consensus as to their
relative contributions Although it has been suggested
that hyponatraemia is associated with worse outcome
and should be corrected [27], a recent study found that
hyponatraemia is associated with preserved conscious-
ness and even a decreased mortality in severe P. falci-
parum malaria [4]. In the setting of hypovolaemia, the
hyponatraemia was likely related to a continued oral
hypotonic fluid intake in those patients who had pre-
served consciousness and the hyponatraemia required no
therapy beyond rehydration given the observation that
plasma sodium normalized with crystalloid rehydration
within 24 hours after admission [4]. Although the present
study was not designed to investigate the pathophysiol-
ogy of hyponatraemia in malaria, a number of observa-
tions might argue against a role for hypovolaemia in the
pathophysiology of hyponatraemia in the present study.
When prerenal azotaemia and haematocrit were consid-
ered as surrogate markers for hypovolaemia, prerenal
azotaemia was not more common and haematocrit was
not higher in hyponatraemic patients as compared with
normonatraemic individuals. In addition, hyponatraemia
persisted for days in one third of the patients despite
rapid volume resuscitation with normal saline. An expla-
nation for this difference could be that the patients
described by Hanson et al [4] presented late to hospital
and were more ill on admission as evidenced by the high
number of comatose patients and the higher mortality
rate. The inverse relationship between plasma sodium
and GCS could not be reproduced in the present study
but might be underpowered by the relatively low number
of comatose patients. Although speculative, an other
mechanism may have contributed to hyponatraemia in
the present study. It is certainly interesting to note that
the pro-inflammatory cytokine interleukin-6 is elevated
in malaria and also implicated in the non-osmotic release
of vasopressin [28,29]. The delayed normalization of
Figure 3 Receiver operating characteristics curve of serum sodi-
um concentration for malaria severity.
Table 2: Logistic regression analysis showing independent predictors of severe falciparum malaria
Variable β SE βW a l d ' s  χ df P-value Odds ratio (95% CI)
Constant -6.1 1.32 21,400 1 < 0.001 N/A
Serum sodium < 131 mmol/L 2.3 0.62 14,286 1 < 0.001 10.4 (3.1 - 34.9)
C-reactive protein > 175 mg/L 1.6 0.58 7,472 1 0.006 4.8 (1.6 - 15.0)
Lactate dehydrogenase > 750 U/L 1.8 0.58 9,288 1 0.002 5.9 (1.9 - 18.7)
Thrombocytes < 20 × 109/L 3.7 1.03 12,761 1 < 0.001 40.0 (5.3 (302.8)
Leukocytes > 6.5 × 109/L 2.3 0.60 14,384 1 < 0.001 9.7 (3.0 - 31.5)van Wolfswinkel et al. Malaria Journal 2010, 9:140
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serum sodium concentration as was observed in the pres-
ent study, might reflect the persistent elevation of inflam-
matory cytokines, which are known to remain increased
for several weeks in some patients with severe malaria
[30]. Previously, a relationship between the development
of in-hospital hyponatraemia and a rise in CRP was dem-
onstrated, which is not only another illustration of this
mechanism [20] but also in line with the observed corre-
lation between sodium levels and CRP levels in patients
with imported malaria in the present study. Additional
studies are needed to further unravel the intriguing
pathophysiology of hyponatraemia in malaria.
In conclusion, hyponatraemia is common in imported
malaria and associated with severe falciparum malaria.
From a clinical point of view, however, the predictive
power of hyponatraemia for severe malaria is limited.
The precise pathophysiological mechanisms of hypona-
traemia in malaria require further study.
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